Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1991 | 09-1991 | 06-1991 | 03-1991 | 12-1990 | |
| Sales | 2,349,000 | 2,757,000 | 2,730,000 | 2,735,000 | 2,177,000 |
| Cost of Goods | 551,000 | 713,000 | 710,000 | 743,000 | 549,000 |
| Gross Profit | 2,173,000 | 2,044,000 | 2,020,000 | 1,992,000 | 1,978,000 |
| Operating Expenses | 1,207,000 | 1,260,000 | 1,325,000 | 1,288,000 | 1,120,000 |
| Operating Income | 591,000 | 784,000 | 695,000 | 704,000 | 508,000 |
| Other Income | 10,000 | 0 | 0 | 0 | 8,000 |
| Pre-tax Income | 601,000 | 784,000 | 695,000 | 704,000 | 516,000 |
| Income Tax | 156,000 | 221,000 | 205,000 | 211,000 | 147,000 |
| Net Income Continuous | 445,000 | 563,000 | 490,000 | 493,000 | 369,000 |
| Net Income Discontinuous | 65,000 | 0 | 0 | 0 | 57,000 |
| Net Income | $510,000 | $563,000 | $490,000 | $493,000 | $426,000 |
| EPS Basic Total Ops | 0.25 | 0.27 | 0.24 | 0.24 | 0.20 |
| EPS Basic Continuous Ops | 0.21 | 0.27 | 0.24 | 0.24 | 0.18 |
| EPS Basic Discontinuous Ops | 0.03 | N/A | N/A | N/A | 0.03 |
| EPS Diluted Total Ops | 0.25 | 0.27 | 0.24 | 0.24 | 0.20 |
| EPS Diluted Continuous Ops | 0.21 | 0.27 | 0.24 | 0.24 | 0.18 |
| EPS Diluted Discontinuous Ops | 0.03 | N/A | N/A | N/A | 0.03 |
| EBITDA(a) | $591,000 | $784,000 | $695,000 | $704,000 | $508,000 |